Theacrine (TeaCrine).

Theacrine and caffeine are both methylated purines acting on adenosine signalling, and almost every human study of theacrine has given it alongside caffeine rather than alone. That makes the combination the tested condition and theacrine alone the less-tested one. It also means effects reported for a combination product cannot be assigned to theacrine by itself.

Theanine crosses the blood-brain barrier through the large neutral amino acid transporter and interacts with glutamatergic signalling. It is combined with stimulants to smooth the subjective edge rather than to add drive. The pairing is well established with caffeine specifically; with theacrine the reasoning is the same but the trial base is thinner.

Tyrosine hydroxylase converts tyrosine to L-DOPA, the rate-limiting step in catecholamine synthesis, and precursor supply becomes relevant when synthesis demand is high. Theacrine is characterised as influencing dopaminergic signalling, so a precursor sits upstream of that. This is a substrate relationship, not evidence of a combined effect.

Choline acetyltransferase needs free choline to make acetylcholine, and alpha-GPC supplies it in a form that reaches the central compartment. Cholinergic and adenosinergic mechanisms are separate, which is why the two appear together in pre-workout and focus blends. The pairing is complementary rather than reinforcing.

Citicoline enters the Kennedy pathway for phosphatidylcholine synthesis and also raises free choline for acetylcholine production. It occupies the same formulation slot as alpha-GPC with a different secondary contribution. Combining it with a purine alkaloid is standard nootropic construction.

Creatine kinase transfers a phosphate from phosphocreatine to ADP, sustaining ATP during the first seconds of maximal effort. That is a peripheral energetic mechanism with no overlap with adenosine receptor activity. Pre-workout formulas carry both because they address different limits on the same session.

Carnosine synthase condenses beta-alanine with histidine, and beta-alanine supply is what limits how much carnosine muscle accumulates. The buffering effect builds over weeks, unlike the acute effect of a purine alkaloid. The two sit in the same product for different time courses.

Oral citrulline raises plasma arginine more reliably than oral arginine does because it bypasses intestinal and hepatic arginase. The resulting nitric oxide signalling affects vascular tone, a peripheral mechanism distinct from central stimulation. It is the standard vascular component alongside a stimulant.

Taurine modulates intracellular calcium handling and acts at inhibitory receptor sites, which is why it appears in stimulant formulas as a counterweight component. It also participates in mitochondrial tRNA modification. Its role alongside purine alkaloids is conventional formulation practice rather than a tested combination.

Rhodiola is standardised to rosavins and salidroside and is positioned around perceived effort rather than acute arousal. Stacking it with a purine alkaloid combines a slower adaptogenic component with an acute one. No combination trial is available here.

Bacopa's effects on memory measures build over a multi-week course, which is a different time scale from an acute purine alkaloid. Formulas combine them so a product has both a same-day and a cumulative component. The pairing is formulation convention.

By slowing acetylcholine breakdown at the synapse, huperzine A raises cholinergic tone from the clearance side while a choline donor raises it from the supply side. Neither mechanism touches adenosine signalling. Its long duration of action is the reason dosing schedules for it differ from those of the stimulant it sits beside.

Adenosine accumulation across waking hours is a core sleep pressure signal, and blocking its receptors works against sleep onset. Melatonin acts on circadian timing through MT1 and MT2 receptors. Taking the two close together sets one against the other, which is why stimulant and sleep formulas are dosed at opposite ends of the day.

Valerian is used for its sedative-direction activity through GABAergic mechanisms. A purine alkaloid pushing the opposite way in the same window means the two work against each other. Separate them in time rather than combining them.

ATP is functionally Mg-ATP, so magnesium sits behind every energy-transfer step a stimulant formula is nominally aimed at. It also blocks the NMDA channel pore at rest, a separate neural role. Adequate status is a background requirement rather than a stimulant partner.

Every monoamine neurotransmitter passes through a PLP-dependent decarboxylation step on the way to being made. A formula supplying tyrosine as precursor needs B6 for that step to run. This is a cofactor dependency and holds regardless of what else is in the product.

Theacrine is a purine alkaloid found in kucha tea, where it accumulates in place of much of the caffeine found in ordinary Camellia sinensis. Green tea extracts bring catechins and their own caffeine content to a formula. Anyone stacking the two should count the total purine alkaloid load, not just the labelled theacrine.

Sodium bicarbonate raises blood pH and bicarbonate concentration, increasing the gradient for hydrogen ion efflux from working muscle. That addresses a different limit from central arousal. Gastrointestinal discomfort is the recognised trade-off and is dose and timing dependent.

Sweat losses shift plasma volume and electrolyte concentrations during prolonged effort, affecting both perceived effort and neuromuscular function. A stimulant does nothing about that. Formulas aimed at longer sessions carry both for that reason.